Abstract:An increasing number of artemisinin (ARS) and its derivatives have been reported for their potential therapeutic value of human cancer. However, their therapeutic potencies are limited owing to their poor pharmacokinetic profiles. Our previous studies showed that a lead compound ARS4 originated from incorporating the pharmacophore of the approved chemotherapeutic agent melphalan into the basic skeleton of artemisinin with a succinic linker exhibited an excellent toxicity to human ovarian cancer cells and low cytotoxicity to normal cells. The mechanism studies demonstrated that it inhibited the growth and proliferation of ovarian cancer cells and resulted in S-phase arrest, apoptosis and inhibition of migration. Meanwhile, it exhibited excellent antitumor activities in animal models. Herein, further structure optimization for this lead compound ARS4 was performed and nineteen novel derivatives were designed and synthesized. Among them, compounds 10-12, 15, 16, 18 and 19 demonstrated powerful cytotoxic effects against human liver cancer and ovarian cancer cell lines, with their IC50s below 0.86 μM against Hep3B and A2780 cell lines, which are superior to that of ARS4. Four compounds (11, 15, 16 and 18) were selected to further evaluate their antitumor activities in in vitro and in vivo ovarian and liver cancer models, the results indicated that compound 18 exhibited the best therapeutic effect, not only effectively inhibited the growth of 7404 xenograft and Huh7 xenograft, but also presented a good dose-dependent inhibition toward the growth of A2780 xenograft. Overall, based on these positive results, these novel chemical structures may provide a new inspiration for the discovery of novel antitumor agents originated from artemisinin scaffolds.

Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

[Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Substituted by N-heterocycles].

Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers

Discovery of novel dihydroartemisinin-cinnamic hybrids inducing lung cancer cells apoptosis via inhibition of Akt/Bad signal pathway

[Design, Synthesis and Antiproliferative Activity in Cancer Cells of Novel Dihydropyrazolyl and Pyrazolyl Artemisinin-Phenyl Ethers].

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties

Synthesis and in Vitro Antitumor Evaluation of Dihydroartemisinin-Cinnamic Acid Ester Derivatives.

Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents

Synthesis of Novel Ring-Contracted Artemisinin Dimers with Potent Anticancer Activities.

Synthesis, Anticancer Evaluation and Pharmacokinetic Study of Novel 10-O-phenyl Ethers of Dihydroartemisinin

Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug

Design, synthesis and biological evaluation of marine naphthoquinone-naphthol derivatives as potential anticancer agents

Discovery of Novel Arylamide Derivatives Containing Piperazine Moiety As Inhibitors of Tubulin Polymerisation with Potent Liver Cancer Inhibitory Activity.

Novel Dihydroartemisinin Dimer Containing Nitrogen Atoms Inhibits Growth of Endometrial Cancer Cells and May Correlate with Increasing Intracellular Peroxynitrite.

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway

Two Novel Camptothecin Derivatives Inhibit Colorectal Cancer Proliferation Via Induction of Cell Cycle Arrest and Apoptosis in Vitro and in Vivo

A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma

Novel Phenylmethylenecyclohexenone Derivatives As Potent Trxr Inhibitors Display High Antiproliferative Activity And Induce Ros, Apoptosis, And Dna Damage

Discovery of Novel Quinoline-Chalcone Derivatives As Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.